Editas Medicine (EDIT) Accumulated Depreciation & Amortization (2016 - 2025)
Historic Accumulated Depreciation & Amortization for Editas Medicine (EDIT) over the last 11 years, with Q3 2025 value amounting to $27.5 million.
- Editas Medicine's Accumulated Depreciation & Amortization fell 977.07% to $27.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.5 million, marking a year-over-year decrease of 977.07%. This contributed to the annual value of $31.6 million for FY2024, which is 2051.79% up from last year.
- Latest data reveals that Editas Medicine reported Accumulated Depreciation & Amortization of $27.5 million as of Q3 2025, which was down 977.07% from $26.8 million recorded in Q2 2025.
- In the past 5 years, Editas Medicine's Accumulated Depreciation & Amortization ranged from a high of $31.6 million in Q4 2024 and a low of $12.0 million during Q1 2021
- Over the past 5 years, Editas Medicine's median Accumulated Depreciation & Amortization value was $23.5 million (recorded in 2023), while the average stood at $22.6 million.
- Per our database at Business Quant, Editas Medicine's Accumulated Depreciation & Amortization soared by 4979.38% in 2021 and then plummeted by 977.07% in 2025.
- Quarter analysis of 5 years shows Editas Medicine's Accumulated Depreciation & Amortization stood at $15.5 million in 2021, then soared by 38.81% to $21.5 million in 2022, then rose by 21.99% to $26.3 million in 2023, then grew by 20.52% to $31.6 million in 2024, then decreased by 12.96% to $27.5 million in 2025.
- Its last three reported values are $27.5 million in Q3 2025, $26.8 million for Q2 2025, and $27.7 million during Q1 2025.